Metabolic liver diseases can be divided into conditions that cause structural liver impairment such as alpha-1-antitrypsin (AAT) deficiency, Wilson’s disease, and disorders that manifest extrahepatically such as urea cycle disorders, hereditary tyrosinaemia type 1, and glycogen storage diseases. The gene discussed is SERPINA1; the disease is alpha 1-antitrypsin deficiency.